SiSaf Ltd
Rachel Sully is a Senior Formulation Chemist at SiSaf Ltd, having previously worked as a Research and Development Scientist at PocDoc. Before that, Rachel was a Postdoctoral Research Associate at The University of Sheffield. Rachel completed their Doctor of Philosophy in Chemistry and Drug Delivery at Medway School of Pharmacy and holds a Masters degree in Chemistry from the University of Kent. Rachel attended Colfe's School from 2007 to 2014.
This person is not in any offices
SiSaf Ltd
SiSaf is an RNA delivery and therapeutics company. Its proprietary Bio-Courier® technology addresses the limitations of other RNA delivery technologies through the hybridization of organic materials with inorganic bioabsorbable silicon.The company’s Bio-Courier portfolio includes silicon stabilized hybrid lipid nanoparticles (sshLNP) that improvethe stability, safety, and transfection efficiency of RNA. SiSaf uses sshLNP to develop a pipeline of RNA therapeutics for rare genetic disorders and is maximizing the potential of its technology through research partnerships.Led by founder and leading biomaterials specialist Dr Suzanne Saffie-Siebert, SiSaf is a venture capital backed private company. Headquartered in Guildford, UK, it has fully integrated research labs and bio-analytical facilities, a scalable technology to fast-track development, and a growing patent estate with extensive freedom to operate.